-
Featured
Tau PET Imaging May Help Identify People with Pre-symptomatic Alzheimer’s Disease
Brain changes associated with Alzheimer’s disease can now be studied in living people. Mass General researchers imaged cognitively normal people who are destined to develop AD due to a rare genetic mutation. Their goal: to discover how soon brain changes are present before symptoms begin and how soon preventive treatments could be initiated.
-
Featured
NEJM Images in Clinical Medicine: Using Ventriculoperitoneal Shunt Placement to Treat Normal-pressure Hydrocephalus
Neurologists at Mass General explore the case of a woman who endured gait disturbance, cognitive impairment and urinary incontinence for 2 years before she was diagnosed with normal-pressure hydrocephalus and successfully treated with surgical shunting.
-
Featured
fMRI and EEG May Find Signals of Consciousness Earlier in Severe Traumatic Brain Injury Patients
The rate of misclassification of unconsciousness can be as high as 40%. A Mass General team studied using fMRI and EEG to better identify patients with unconsciousness in the ICU.
-
Tau Damages Neurons in Alzheimer's Disease by Disrupting Molecular Transport
Neurologists at Massachusetts General Hospital have determined that tau fibril formation, one of the pathological hallmarks of Alzheimer's disease, disrupts molecular transport in neurons—suggesting a potential new therapeutic strategy.
-
Using Stem Cells to Treat Movement Disorders
In this video, Jeffery Schweitzer, MD, PhD, discusses his research using stem cell technology to restore normal function in patients with movement disorders. He believes this technology may be able to improve outcomes for patients with tremor, Parkinson's disease and dystonia.
-
Fingolimod is Superior to Interferon Beta-1a for Relapsing MS in Children 10 and Older
A randomized, active-comparator, double-blind, multinational phase 3 trial has established the efficacy and safety of fingolimod for patients with relapsing multiple sclerosis who are 10 and older. The drug is now FDA approved for that population.
Neurology contributors
-
Brian L. Edlow, MD
Associate Director, Center for Neurotechnology and Neurorecovery (CNTR), Director, Laboratory for NeuroImaging of Coma and Consciousness (NICC), Director, Critical Care Research Neuroimaging
Recent Article
fMRI and EEG May Find Signals of Consciousness Earlier in Severe Traumatic Brain Injury Patients -
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine
Recent Article
Translation, Discovery and Collaboration in Psychiatry
-
Keith A. Johnson, MD
Radiologist
Recent Article
Tau PET Imaging May Help Identify People with Pre-symptomatic Alzheimer’s Disease
-
Nagagopal Venna, MD
Director, Neurology Clinic, Director, Neuro-Infectious Diseases Clinic, Director, Academic General Neurology Fellowship Program
Recent Article
NEJM Images in Clinical Medicine: Using Ventriculoperitoneal Shunt Placement to Treat Normal-pressure Hydrocephalus
-
Yakeel T. Quiroz-Gaviria, PhD
Co-Director, MGH Multicultural Neuropsychology Program (MUNDOS)
Recent Article
Research Advances from Mass General Neurology
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
